Correction for Caligiuri et al., Arterioscler Thromb Vasc Biol 25 (4) 655-657.

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:e140.)
© 2005 American Heart Association, Inc.

Correction

An extract of the first 100% of the full text is provided, because this article has no abstract.

In the April 2005 issue of Arteriosclerosis, Thrombosis, and Vascular Biology, in the editorial by Caligiuri et al (Arterioscler Thromb Vasc Biol. 2005:25:655–657.), a reference was mistakenly omitted from the first line of the fourth paragraph. The complete statement, with the appropriate citation and reference, is listed below. The authors regret this error.

Previous studies have shown that blocking IL–18 signaling by overexpression of the IL–18 binding protein (the endogenous inhibitor of IL–18) prevents fatty streak formation and slows progression to mature plaque.^14a

^14aMallat Z, Corbaz A, Scoazec A, Graber P, Alouani S, Esposito B, Humbert Y, Chvatchko Y, Tedgui A. Interleukin–18/interleukin–18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res.2001;89:e41–e45.